Atlas Trials

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

Clinical trial NCT06680232 · RECRUITING

Trial details

NCT number
NCT06680232
Sponsor
Precision BioSciences, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HEPATITIS B CHRONIC
Start date
2024-11-14
Primary completion
2026-12-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.